<!-- agent_run_sha256: 2658cfae6c0debdb6b6161ed4e0df774c2972dc5987773875b554fce1da575bd -->
> **UNAPPROVED DRAFT - pending human review**

## Cohort
The cohort consists of 501 patients, with 497 having their expression data available. The missingness analysis reveals that the 'age' variable has the highest proportion of missing values at 2%, while 'sex', 'stage', 'mut_TP53', 'mut_KRAS', 'mut_EGFR', 'mut_STK11', and 'mut_KEAP1' variables have no missing values. The 'stage' variable has 2 missing values, which constitute 0.004 of the total dataset. No patients had missing 'os' (overall survival) data, but 61 patients had missing 'os' months data, which is a concern that should be addressed to ensure the integrity of the survival analysis.

## Models and metrics
The models passed all checks ensuring integrity, leakage, proportional hazards, and convergence. The clinical models (cox/clinical, rsf/clinical) and clinical expression models (cox/clinical_expression, rsf/clinical_expression) are the focus of our discussion. We will discuss the Harrell C, Uno C, AUC at 12 months, AUC at 24 months, AUC at 36 months, and Integrated Brier Score over 6 to 36 months as metrics of interest.

## Checks and abstentions
The checks include split integrity, min events, leakage, proportional hazards, and convergence. The split integrity and min events checks passed. The leakage check also passed, indicating that the imputation methods did not introduce any systematic biases. The proportional hazards test passed, with no covariates below the 0.01 significance level. The convergence check passed, with a log-likelihood of -609.0508613985864.

## Limitations
The cohort summary indicates that the 'age' variable has a high proportion of missing values, which could introduce bias if not handled appropriately. The 'stage' variable has a small number of missing values, which might require further investigation to understand the reasons for these missing values and how they could affect the study's outcomes. The presence of missing 'os' months data in 61 patients is a concern that should be addressed to ensure the integrity of the survival analysis. The models passed all checks ensuring integrity, leakage, proportional hazards, and convergence, but the high proportion of missing 'age' data and the small number of missing 'stage' data are limitations that should be considered.
